Advertisement

Topics

Ecopia Biosciences Incorporated Company Profile

09:44 EDT 19th September 2017 | BioPortfolio

Ecopia Biosciences Inc. is an extraordinarily exciting new Biotechnology company, committed to discovering and developing new therapeutic products through the application of state-of-the-art genomics and bioinformatics technology.

Location

2310 Aflred-Nobel
Saint-Laurent
Quebec
H4S 2A4
Canada

Contact

Fax: (514)336-8827
Email: yang@ecopiabio.com


News Articles [671 Associated News Articles listed on BioPortfolio]

Ricerca Biosciences, LLC Renamed to Concord Biosciences, LLC After Sale of Chemical Development ...

According to Clifford W. Croleyof Main Market Partners and the CEO of Concord Biosciences, "We are very pleased to focus our complete energies Read more...

Apricus Biosciences, Inc.: Apricus Biosciences Regains Compliance with Nasdaq Continued Listing Requirements

SAN DIEGO, 2017-05-02 22:05 CEST (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced...

Daily Technical Summary Reports on Drug Makers Stocks -- Apricus Biosciences, DURECT, Sucampo ...

http://dailystocktracker.com/register/ Apricus Biosciences  On Tuesday, shares in San Diego, Californiaheadquartered Apricus Biosciences Inc. recorded a trading volume of 128,247 shares. The stoc...

Apricus Biosciences, Inc.: Apricus Biosciences Announces the Initiation of Vitaros Drug-Device Human Factors Study

Vitaros U.S. NDA Re-Submission on Track for Third Quarter 2017SAN DIEGO, 2017-05-04 13:00 CEST (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing inn...

Apricus Biosciences, Inc.: Apricus Biosciences Announces Corporate Update and First Quarter 2017 Financial Results Conference Call

SAN DIEGO, 2017-05-04 12:45 CEST (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced...

Reviewing Catalyst Biosciences

Catalyst Biosciences and Fortress Biotech are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, valu...

Pressure BioSciences, Inc. to Present at the 19th Annual Rodman Renshaw Global Investment ...

SOUTH EASTON, MA--(Marketwired - Sep 11, 2017) - Pressure BioSciences, Inc. ( OTCQB : PBIO) ("PBI" and the "Company"), a leader in the Read more...

Deals this week: Selecta Biosciences, bluebird bio, TransGenic

Selecta Biosciences intends to raise $50m through private placement of shares of its common stock to be subscribed to by new and existing institutional investors and one of the company’s board of di...

Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy

The purpose of this research is to determine if a subject's own bone marrow tissue can help regenerate bone in the area of his/her jaw where a tooth has been removed using Tissue Repair Ce...

Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data

We seek to improve the predictive accuracy of the nomogram to predict survival for patients with castrate mets disease through the addition of pathological data, the results of automated m...

Validation of Decipher Test in African American Men With Prostate Cancer - VANDAAM

The primary purpose of this study is to determine whether a tumor test recently developed by GenomeDx Biosciences known as Decipher® can predict aggressive prostate cancer with the same a...

Validation of Lophius Kits T-Track® CMV and T-Track® EBV in Hemodialysis Patients

Cell-mediated immunity (CMI) and in particular T cells play a critical role in the rejection of transplanted organs. Thus, in transplant recipients a life-long and individualized immunosup...

Companies [375 Associated Companies listed on BioPortfolio]

Ecopia Biosciences Incorporated

Ecopia Biosciences Inc. is an extraordinarily exciting new Biotechnology company, committed to discovering and developing new therapeutic products through the application of state-of-the-art genomics ...

Ecopia BioSciences

Ecopia was created in January 1998 through a private placement of approximately $1.8 million at $0.20 per share, involving Theratechnologies Inc. ("Theratechnologies") and private investors. From its ...

Hydra Biosciences, Inc.

Hydra Biosciences is a privately-held biopharmaceutical company based in Cambridge, Massachusetts, and develops drugs to treat pain, inflammation, anxiety and other diseases using...

Leadiant Biosciences, Inc.

Leadiant Biosciences, Inc. (formerly Sigma-Tau Pharmaceuticals, Inc.) is a U.S.-based, wholly owned subsidiary of Leadiant Biosciences S.p.A., a research-based pharmaceutical comp...

JeNu Biosciences

JeNu Biosciences was founded in 2008 by a team of ultrasound scientists, medical doctors and beauty executives and is currently led by Wayne Wager, CEO. JeNu Biosciences is a Seat...

More Information about "Ecopia Biosciences Incorporated" on BioPortfolio

We have published hundreds of Ecopia Biosciences Incorporated news stories on BioPortfolio along with dozens of Ecopia Biosciences Incorporated Clinical Trials and PubMed Articles about Ecopia Biosciences Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ecopia Biosciences Incorporated Companies in our database. You can also find out about relevant Ecopia Biosciences Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record